Plant-derived bioactive peptides have good market development prospects and market demand is growing

​​Biologically active peptides are intermediate products of protein hydrolysis. They are a specific protein fragment, a sequence composed of 2 to 20 amino acids, and their molecular weight is less than 10kDa. Since bioactive peptides are a type of small molecule compounds, digested bioactive peptides can be directly absorbed by the intestines, thus increasing their availability in the organism. Plant-derived bioactive peptides can be divided into antioxidant peptides, blood pressure-lowering peptides, antimicrobial peptides, hypoglycemic peptides, hypolipidemic peptides, anti-cancer peptides and anti-inflammatory peptides according to their functions.

Plants are a valuable source of bioactive peptides. Compared with animals, plant resources are more abundant, highly renewable and cheaper. Obtaining bioactive peptides from plants will become a development trend. Especially in recent years, many excellent functions of plant active peptides have been discovered, such as antioxidant, anti-cancer, lowering blood pressure, antibacterial, improving memory, lowering blood lipids and maintaining blood sugar balance in the body. Based on this excellent quality, bioactive peptides are used in The pharmaceutical industry has excellent application prospects, and researchers from all over the world want to develop functional peptides as ideal substitutes for synthetic drugs. Not only that, in addition to its therapeutic effect, it can also prevent or reduce the risk of some diseases.

According to the “Research Report on Market Monitoring and Future Development Prospects of China’s Plant-Derived Bioactive Peptide Industry from 2023 to 2027” released by the Industrial Research CenterIt shows that with the continuous release of policy dividends, industries related to “big health” have entered a period of vigorous development and gradually formed new economic growth points, also attracting the influx of a large amount of capital. The plant-derived bioactive peptide industry is in line with the development concept of the great health industry. Various favorable policies for the great health industry, and the gathering of capital and talents also provide good opportunities for the development of my country’s plant-derived bioactive peptide industry.

In recent years, due to various factors such as unbalanced diet, irregular work and rest, and excessive life pressure, a series of health problems such as hyperlipidemia, high blood pressure, and high blood sugar have become increasingly serious. We are looking for a natural source, obvious effect, and good for human health. Treatment drugs without adverse effects are urgently needed. As technology continues to mature and market demand increases, new companies continue to enter the plant-derived bioactive peptide industry in my country, but the production scale of the new companies is generally small. Under this situation, in order to seize more market share, competition among enterprises mainly revolves around price, resulting in fierce market competition in the plant-derived bioactive peptide industry. It is expected that in the future, the number of companies in my country’s plant-derived bioactive peptide industry will show a growth trend.

Industrial researchers believe that China has a large population base and a huge market space. With the improvement of China’s consumption level and the sudden outbreak of the epidemic, The continuous changes and deepening of the people’s health concept have made the people pay more attention to the nutritional supplement and functional needs of food. The demand for health products and dietary nutritional supplements continues to grow, which will lead to the continuous growth of the demand for plant-derived bioactive peptides.